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ABSTRACT
In G2 phase cells, DNA double-strand break repair
switches from DNA non-homologous end-joining to
homologous recombination. This switch demands
the promotion of resection. We examine the
changes in 53BP1 and RAP80 ionizing radiation
induced foci (IRIF) in G2 phase, as these are factors
that restrict resection.We observed a 2-fold increase
in the volume of 53BP1 foci by 8h, which is not seen
in G1 cells. Additionally, an IRIF core devoid of 53BP1
arises where RPA foci form, with BRCA1 IRIF forming
between 53BP1 and replication protein A (RPA).
Ubiquitin chains assessed using a-FK2 antibodies
are similarly repositioned. Repositioning of all these
components requires BRCA1’s BRCT but not the ring
finger domain. 53BP1, RAP80 and ubiquitin chains
are enlarged following POH1 depletion by small
interfering RNA, but a devoid core does not form
and RPA foci formation is impaired. Co-depletion of
POH1 and RAP80, BRCC36 or ABRAXAS allows es-
tablishment of the 53BP1 and ubiquitin chain-devoid
core. Thus, the barriers posed by 53BP1 and RAP80
are relieved by BRCA1 and POH1, respectively.
Analysis of combined depletions shows that these
represent distinct but interfacing barriers to
promote loss of ubiquitin chains in the IRIF core,
which is required for subsequent resection. We
propose a model whereby BRCA1 impacts on
53BP1 to allow access of POH1 to RAP80. POH1-de-
pendent removal of RAP80 within the IRIF core
enables degradation of ubiquitin chains, which
promotes loss of 53BP1. Thus, POH1 represents a
novel component regulating the switch from non-
homologous end-joining to homologous
recombination.
INTRODUCTION
DNA non-homologous end-joining (NHEJ) and homolo-
gous recombination (HR) represent the two major
pathways for DNA double-strand break (DSB) repair.
NHEJ occurs throughout the cell cycle; HR occurs only
in S/G2 phase (1). HR also repairs one-ended DSBs at
stalled/collapsed replication forks in S phase (2).
Regulation between HR versus NHEJ is complex but
critical for the maintenance of genomic stability after
DSB generation. Although NHEJ must be avoided at
one-ended DSBs, current evidence suggests that NHEJ
repairs the majority of DSBs in G2 phase, but if NHEJ
does not ensue, then resection occurs committing to repair
by HR (3,4). Thus, depending on the situation, NHEJ is
either avoided or there is a controlled switch from NHEJ
to HR. Current evidence suggests that regulating resec-
tion, an early event in HR, represents a critical step
determining the commitment to HR (4).
The DNA damage signalling response (DDR) to DSBs
involves the orchestrated assembly of DDR proteins at the
DSB site (5,6). The MRE11/RAD50/NBS1 (MRN)
complex recruits Ataxia and telangiectasia mutated
protein (ATM), which phosphorylates H2AX aiding re-
cruitment of the mediator protein, MDC1, and tethering
of MRN and ATM at the DSB. The ubiquitin ligases,
RNF8 and RNF168, are then recruited (5). Subsequent
generation or exposure of methylated histone residues
aids the localization of 53BP1, another mediator protein
(7,8). This assembly is visualized as ionizing radiation
induced foci (IRIF) at DSBs. This occurs in all cycle
phases whilst another branch of recruited proteins that
include BRCA1, RAP80, ABRAXAS, and BRCC36,
form either uniquely or more robustly in G2 phase (9).
The recruitment of these latter proteins is dependent on
RNF8-dependent ubiquitylation but independent of
53BP1. The 53BP1 has been described as a factor restrict-
ing resection and hence HR, and I-Sce1 reporter assays for
HR have shown that small interfering RNA (siRNA)
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53BP1 leads to enhanced HR (10). BRCA1, in contrast,
supports HR with siRNA BRCA1 leading to a deﬁciency
in HR (11). Strikingly, loss of 53BP1 relieves the require-
ment for BRCA1 for HR, suggesting that a major role of
BRCA1 is to overcome a barrier to resection posed by
53BP1 (12–14). Supporting a model of this nature, a
recent study proposed that BRCA1 promotes HR by
excluding 53BP1 to the IRIF periphery, thereby
overcoming 53BP1’s inhibitory barrier on HR (15).
A complex encompassing RAP80, BRCC36 and
ABRAXAS represents another factor that inhibits resec-
tion and promotes NHEJ (16–18). Indeed, RAP80 siRNA
leads to unbridled resection and enhanced HR. RAP80
has a tandem ubiquitin interaction motif allowing it to
bind to Lys63-linked ubiquitin polymers (17,19). Thus,
RAP80 binds to Lys63-linked ubiquitin residues, which
arise at IRIF as a consequence of the ubiquitin ligases,
RNF8 and RNF168. It has been proposed that RAP80
serves to inhibit resection by binding to ubiquitin chains
(17,18). POH1, a deubiquitylating enzyme (DUB) and
component of the proteasome, has recently been shown
to regulate 53BP1 via an ability to counteract RNF8/
RNF168 dependent ubiquitin activity (20).Consequently,
53BP1 foci are enlarged in cells depleted for POH1.
Additionally and distinctly, POH1 has a role in HR
promoting the loading of RAD51.
Here, we examine changes in IRIF that arise in G2 cells
during the switch from NHEJ to HR. Using Z-stacked
immunoﬂuorescence imaging and 3D reconstruction, we
show that 53BP1 and ubiquitin chains but not gH2AX
undergo a G2 phase-speciﬁc enlargement via a process
requiring BRCA1’s BRCT domain. Additionally,
BRCA1 promotes the formation of a core devoid of
53BP1 and ubiquitin chains in G2 phase in which RPA
foci arise. As reported previously, 53BP1 foci are enlarged
in G1 and G2 phase following POH1 depletion, but we
show here that POH1 has a distinct role in generating a
core devoid of 53BP1 and ubiquitin chains in G2 cells,
thereby promoting RPA foci formation (20).The require-
ment for POH1 for generation of a devoid core can be
relieved by depletion of any member of the RAP80/
BRCC36/ABRAXAS complex. Thus, POH1 relieves a
barrier to resection posed by RAP80. We show that
RAP80 and 53BP1 represent distinct but interfacing
barriers to resection. We propose a model whereby
BRCA1 impacts on 53BP1 to allow access of POH1 to
the ubiquitin chains, which in turn facilitates the
removal of 53BP1, relieving the barrier to resection.
MATERIALS AND METHODS
Cell culture and irradiation
A549 and mouse embryonic ﬁbroblast (MEF) cells were
cultured in Dulbecco’s modiﬁed Eagle’s medium with
10% Foetal Calf Serum (FCS), L-glutamine, penicillin
and streptomycin at 37C in a humidiﬁed 95% air
and 5% CO2 atmosphere. Cells were irradiated by
exposure to a 137Cs source. For G2 experiments,
aphidicolin (3 mg/ml) was added to cells before IR to
prevent S-phase cells from progressing into G2. Unless
otherwise stated, all results represent the mean and SD
of three experiments.
siRNA knockdown conditions
siRNA-mediated knockdown was achieved using
HiPerFect Transfection Reagent (Qiagen, Hilden,
Germany) following the manufacturer’s instructions.
siRNA duplexes were transfected into 2 105 of logarith-
mically growing cells per condition. Cells were then grown
for 72 h before IR. BRCA1 (50-GGAACCUGUCUCCAC
AAAG-30) POH1 (50- AGAGUUGGAUGGAAGGUU
U-30) and Abraxas (50-CATCGACTGGAACATTCCTT
ATATA-30) siRNA oligonucleotides were StealthTM
RNAi oligos from Invitrogen. BRCA1, Artemis,
BRCA2, BRCC36, RAP80, POH1, KAP-1 and CtiP
siRNA oligonucleotides were obtained from the
Dharmacon SMARTpool. The full list of target sequences
from the Dharmcacon ON-TARGETplus SMARTpool is
provided in Supplementary Figure S6B.
Immunoﬂuorescence
Cells plated on glass slides were ﬁxed for 10min with
ﬁxative [3% (w/v) paraformaldehyde (PFA), 2% (w/v)
sucrose, 1 PBS] and permeabilized for 1min with 0.2%
Triton X-100 in PBS. When staining for RPA and RAD51
foci, pre extraction was performed by treatment with 0.2%
Triton X-100 in PBS for 0.5–1min before PFA ﬁxation.
Cells were rinsed with PBS and incubated with primary
antibody diluted in PBS+2% (w/v) BSA for 1 h at room
temperature (RT). Cells were washed three times,
incubated with secondary antibody [diluted in PBS+2%
(w/v) BSA] for 30min at RT in the dark, incubated with
40,6-diamidino-2-phenylindole (DAPI) for 10min and
washed three times with PBS. In cases where quadruple
staining was used (Figure 2), the cells were initially
incubated with three compatible antibodies, followed by
staining with their corresponding secondary antibodies.
The cells were then sequentially stained with a fourth
antibody and subsequently stained with a compatible sec-
ondary antibody. In all cases, slides were mounted using
Vectashield and visualized/analysed using a Nikon-e400
microscope and imaged using an Applied Precision
Delta Vision RT Olympus IX70 deconvolution micro-
scope and softWoRx Suite software. In each sample, a
minimum of 30 cells was scored blindly, and error bars
represent the SD between three experiments. Co-
localization analysis (S2B) was undertaken using
softWoRx Suite software. The Pearson Coefﬁcient of
Correlation indicates how closely two intensities co-localize
on a pixel-by-pixel basis (full co-localization is 1.0).
Z stack imaging and 3D modelling
Z-stack imaging was carried out using an Applied
Precision Delta Vision RT Olympus IX70 deconvolu-
tion microscope and softWoRx Suite software. Z-stacks
were set at 2 mm, and individual nuclei was imaged using
100 magniﬁcation. Deconvolution was performed by the
Huygens Professional image processing software package
(PSF- Theoretical, Max iterations- 400, Quality change
threshold- 0.01). The 3D model conversions of these
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images using the softWoRx Suite are displayed
(Figures 2 and 4) and were subsequently magniﬁed and
displayed either as solid or wireframe structures.
Wireframe images allow visualization of the inner
regions of IRIF. Line plots (Figures 2–5) were performed
by the softWoRx Suite software on a minimum of 10
cells from each of three independent experiments. Error
bars represent the SD.
Foci volume quantiﬁcation
Z-stack images were acquired and deconvolved as
described earlier in the text. IRIF volume quantiﬁcation
was subsequently undertaken using the ‘surface’ tool of
the BitPlane Imaris image processing software. In each
sample, a minimum of 10 cells were analysed from each
of three independent experiments. Error bars represent the
minimum and maximum valid values. Maximum valid
values, determined as the highest datum still within the
1.5 interquartile range of the upper quartile, were used
to eliminate abnormally large values arising from foci
‘clumping’ and resolution limitations. Statistical analysis
was carried out using the Mann–Whitney Rank Sum test.
Data were deemed to be signiﬁcant when a P< 0.05 was
obtained.
Antibodies
The primary antibodies used were as follows: gH2AX
(mouse) and 53BP1 (mouse) (Upstate Technology,
Billerica, USA) at 1:800, 53BP1 (rabbit) (Bethyl,
Cambridge, England) at 1:800, RPA (rat) (Calbiochem,
Billerica, USA) at 1:800, RPA (mouse) (Lifespan
Biosciences, Suffolk, UK) at 1:100, Phospho RPA32
(S4/S8) (mouse) (Bethyl, Cambridge, UK), RAD51
(rabbit) (Santa-Cruz Biotechnology, Santa Cruz, USA)
at 1:200, p-histone H3 (p-H3) Ser10 (mouse) (Upstate
Biotechnology, Buckingham, UK) at 1:500; FK2
(mouse) (Millipore, Billerica, USA) at 1:400, RAP80
(rabbit) (Epitomics, Burlingame, USA) at 1:400. The
antibodies against the human proteins BRCA1, RAP80
and MDC1 were raised in rabbits injected with the follow-
ing antigens: amino acids 1350–1650 for BRCA1, 1–400
for RAP80 and 500–800 for MDC1. In all cases, the cor-
responding cDNA fragment was cloned into the pET-28
expression vector (Novagen, Billerica, USA) to express
his-tagged fusion proteins in Escherichia coli. Once
expressed, the proteins were puriﬁed using Ni-NTA resin
(Qiagen, Hilden, Germany) following manufacturer’s in-
structions and were inoculated in rabbits to raise
antibodies using standard procedures (Harlow and Lane,
1988).
The following secondary antibodies were as follows:
FITC (Sigma Aldrich, Poole, UK) at 1:200, CY3 (Sigma
Aldrich, Poole, UK) at 1:200, Alexa 488, Alexa647
and Alexa 555 (Invitrogen, Grand Island, USA) all
at 1:400.
The RNF168-GFP construct was generated by Dr G.
Stewart, University of Birmingham.
RESULTS
BRCA1 functions downstream of CtIP-dependent
initiation of resection
To monitor HR at two-ended DSBs and avoid the analysis
of one-ended DSBs that can arise in S phase, we speciﬁc-
ally examine irradiated G2 cells using the cell cycle
marker, CENPF, and add aphidicolin to prevent S
phase cells progressing into G2 during analysis.
Extensive control experiments have shown that this does
not impair DSB repair by either NHEJ or HR nor signiﬁ-
cantly increase the level of IRIF in undamaged cells (3,4).
Two hours post 3Gy IR, cells depleted for BRCA1 or
BRCA2 show the same level of DSB repair, monitored
by enumerating gH2AX foci, as control cells, consistent
with previous ﬁndings that rapid DSB repair in G2 occurs
by NHEJ (Figure 1A) (3,4). In contrast, a subtle but
reproducible DSB repair defect is observed by 8 h, repre-
senting those DSBs repaired with slow kinetics by HR
(Figure 1A). Longer times post-IR cannot be readily
monitored by this procedure owing to mitotic progression.
CtBP-interacting protein (CtIP) is required for initiating
resection during HR (16). Previous studies have shown
that siRNA CtIP prevents RPA, RAD51 and sister
chromatid exchanges (SCE) foci formation but DSB
repair occurs efﬁciently by NHEJ (4). Hence, it has been
proposed that CtIP initiates resection, committing to
repair by HR but if this initiation step does not occur,
then repair can proceed by NHEJ. Consistent with this
model, DSB repair after siRNA CtIP is dependent on
XRCC4-like factor (XLF), an NHEJ factor (4).
Consistent with the proposal that depletion of siRNA
CtIP allows NHEJ to repair DSBs, we observed that
siRNA CtIP rescues the DSB repair defect caused by
siRNA BRCA2 in G2 cells (Figure 1A) (4).
In contrast to siRNA CtIP (where no DSB repair defect
is observed in G2, siRNA BRCA1 does confer a G2 DSB
repair defect identical to that shown by cells lacking es-
sential HR components (RAD51 or BRCA2), suggesting
that BRCA1 functions downstream of CtIP, likely at a
stage post the commitment to HR (Figure 1A). To inves-
tigate the order of BRCA1 and CtIP function, we
examined whether CtIP depletion could rescue the G2
repair defect caused by siRNA BRCA1. siRNA
CtIP+BRCA1 relieved the defect observed following
siRNA BRCA1 alone (Figure 1A). Thus, we propose
that CtIP functions upstream of BRCA1 to initiate resec-
tion, committing to repair by HR. BRCA1, in contrast,
functions to complete resection. As CtIP-dependent initi-
ation of resection (the step committing to HR and
precluding the usage of NHEJ) occurs in BRCA1-depleted
cells, DSB repair cannot ensue by NHEJ. As neither HR
nor NHEJ can proceed, a DSB repair defect is observed.
To substantiate this, we examined whether siRNA
BRCA1 could rescue the repair defect in cells lacking
BRCA2, a downstream HR factor required for RAD51
loading (21). We anticipated that if BRCA1 functions
downstream of CtIP-dependent initiation of resection,
siRNA BRCA1 would not rescue the BRCA2 repair
defect, in contrast to the situation following siRNA
CtIP. Indeed, although siRNA CtIP rescued the siRNA
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BRCA2 repair defect, joint siRNA BRCA1+BRCA2
showed defective DSB repair (Figure 1A).
Extending the analysis of where BRCA1 functions, we
examined RPA and RAD51 foci formation following
siRNA CtIP. Consistent with other ﬁndings, siRNA
BRCA1 causes a modest decrease in RPA and RAD51
foci numbers (Figure 1B and C) (22–24). Both endpoints
are almost abolished following siRNA CtIP. As expected,
siRNA BRCA2 does not impair resection (RPA foci
numbers) but prevents RAD51 foci formation
(Figure 1B and C) (4). Importantly, RPA and RAD51
foci numbers remained low following siRNA
BRCA1+CtIP or BRCA2+CtIP. However, as shown in
Figure 1A, DSB repair ensues following either siRNA
BRCA1+CtIP or BRCA2+CtIP. Thus, we argue that
CtIP initiates resection committing to repair by HR. In
the absence of CtIP, DSB repair can ensue by NHEJ (4).
As CtIP can rescue the DSB repair defect following
siRNA of either BRCA1 or BRCA2 in the absence of
detectable resection or RAD51 loading, we propose that
both BRCA1 and BRCA2 function downstream of CtIP-
dependent initiation of resection (Figure 1B and C).
Collectively, we interpret these ﬁndings as showing that
CtIP’s upstream role in initiating resection commits to
repair by HR. If prevented, DSB repair ensues by NHEJ
(4). In contrast, siRNA BRCA1 confers a DSB repair
defect with visible although diminished RPA foci. Thus,
we propose that BRCA1 functions to complete resection
downstream of CtIP’s initiation step. These ﬁndings are
consistent with but extend previous ﬁndings that the
Figure 1. BRCA1 functions downstream of CtIP in G2 to promote resection and 53BP1 repositioning. (A) A549 cells were exposed to 3Gy IR and
gH2AX foci enumerated to 8 h post-IR. G2 cells were identiﬁed by CENPF staining (4). RPA (B) andRAD51 (C) foci in G2 phase A549 cells post
3Gy IR following treatment with the indicated siRNAs. (D and E) Analysis of 53BP1 foci volume in A549 cells following 3Gy IR in untreated cells
(D) and following treatment with siRNA BRCA1 (E). (F) Representative images of nuclei immunostained for 53BP1 at 8 h after 3Gy IR in G1 and
G2 with or without siRNA BRCA1. Scale bars—5mm. BRCA1 knockdown efﬁciency is shown in Supplementary Figure S1.
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resection observed in cells deﬁcient for BRCA1 and 53BP1
is CtIP dependent (12).
53BP1 undergoes repositioning at IRIF during HR
BRCA1 has been proposed to overcome a barrier to HR
created by 53BP1 in asynchronous cells (12,13). We tested
whether BRCA1 has the same role at two-ended DSBs
arising in G2 cells after IR exposure. We observed that
in G2 cells, 53BP1 IRIF enlarge at later times (8 h) post-
IR compared with IRIF in G1. We exploited Z-stacked
immunoﬂuorescence imaging and 3D reconstruction to
quantify IRIF size and organization. In G1, no substantial
change in IRIF volume post-IR using a-53BP1 was
observed, whereas a doubling in 53BP1 foci volume was
seen from 0.5 to 8 h in G2 (Figure 1D). Similar ﬁndings
were recently reported, although the impact here is more
marked most likely because we speciﬁcally examine two-
ended DSBs in G2 (15). siRNA BRCA1 did not affect
IRIF volume in G1 but precluded enlargement in G2,
with IRIF volume resembling that observed in G1
(Figure 1E and F). Whereas 53BP1 localized as a tight
sphere in G1 and at 30min post-IR in G2, in striking
contrast, it both vacated the central core and relocated
to the periphery of enlarged IRIF by 8 h in G2 (Figure
2A and B). Strikingly, 53BP1 repositioning did not occur
following siRNA BRCA1 (Figure 2C). Further, in control
cells at 0.5 and 8 h post-IR, BRCA1 localized internally to
53BP1 (Figure 2A). RPA foci localized to the IRIF core
that became devoid of 53BP1 with BRCA1 being located
between 53BP1 and RPA (Figure 2B). RPA localization to
the IRIF core is consistent with a report of a micro com-
partment of single-strand DNA-binding protein within the
centre of micro-irradiated laser tracks (25).
Ubiquitin chains but not cH2AX relocalize with 53BP1
53BP1 localizes to IRIF via RNF8-RNF168-dependent
H2A ubiquitylation (26). We predicted that 53BP1 repos-
itioning to IRIF periphery might necessitate enlargement
of the region encompassing ubiquitin chains. Using 3D
imaging with a-FK2 antibodies at 8 h post-IR in G2
cells, we observed that the IRIF core was depleted of
the a-FK2 signal, which instead co-localized with 53BP1
(Figure 2A and B; Supplementary Figure S2B). Thus,
FK2 co-localized with 53BP1 at 0.5 and 8 h post-IR in
G2. In contrast, whereas gH2AX localizes externally to
53BP1 at 0.5 h post-IR, it does not relocalize to the
same extent as 53BP1 and is positioned internally to
53BP1 by 8 h post-IR in G2 (Figure 2A and B;
Supplementary Figure S2E). However, gH2AX does
vacate the core where RPA foci form, although the devoid
core is smaller than observed after 53BP1 (Figure 2B; for
further details and discussion, see Supplementary Figure
S2E and F).
To assess whether the inability of 53BP1 foci to enlarge
in BRCA1 depleted cells might be a consequence of
reduced resection (assessed as RPA foci numbers), we
examined 53BP1 foci in cells depleted for the endonuclease
Artemis, which is required for resection in G2 cells, as
Artemis siRNA and BRCA1 siRNA result in a similar
decrease in RPA foci numbers (3). Notably, we observed
a similar 2-fold increase in 53BP1 foci volume in G2 cells
to that seen in control cells, suggesting that BRCA1
directly promotes 53BP1 relocalization during HR rather
than relocalization being an indirect consequence of
impaired resection (Supplementary Figure S2C).
The aforementioned ﬁndings highlight two BRCA1-de-
pendent changes in IRIF that can be visualized by 8 h
post-IR compared with 0.5 h; ﬁrst, the foci enlarge in
volume, but additionally an enlarged core devoid of
53BP1 and ubiquitin chains arises. Quantiﬁcation of the
volume of IRIF at 8 h post-IR has been carefully moni-
tored (Figure 1D and E). As an alternative way to quan-
titatively assess these changes and particularly to monitor
the formation of a devoid core, we sought to monitor the
distribution of DDR proteins at each IRIF along a linear
axis (Figure 2D). This analysis shows that at 8 h post-IR
in G2 cells, 53BP1 and ubiquitin chains are distributed in
a bipolar manner displaying two peaks and a central
trough. Signiﬁcantly, RPA is distributed as a single peak
locating to the 53BP1/ubiquitin chain trough. Moreover, a
single peak distribution for both 53BP1 and ubiquitin
chains is observed following depletion of BRCA1, and
the intensity of the RPA signal is reduced (Figure 2E
and Supplementary Figure S3). Further, the overall
width of the outer territory occupied by 53BP1 or ubiqui-
tin chains is 2-fold greater in control cells compared with
that in cells treated with BRCA1 siRNA, consistent with
the notion that BRCA1 regulates two processes, forma-
tion of a 53BP1-devoid core and enlargement of the 53BP1
foci (Figure 2F).
BRCA1’s BRCT domain promotes 53BP1 repositioning
and creation of a devoid core
To examine the BRCA1 domains required for 53BP1 re-
positioning, we exploited MEFs homozygously expressing
either WT, Brca1, Brca1FH-126A, which inactivates the E3
ligase activity, or Brca1S1598F, which disrupts the BRCT
phospho-recognition domain (27). Analysis using these
cells has shown that BRCA1’s BRCT domain is required
for HR monitored by an I-Sce1 assay (27). Consistent with
this, we observed that RPA and RAD51 focus formation
is diminished in Brca1S1598F MEFs but occurs normally in
Brca1FH-126A MEFs (Figure 3A and B). Furthermore,
although foci expansion was less marked in MEFs
compared with human cells, expansion was evident and
occurs normally in MEFs expressing WT or Brca1FH126A
but not in Brca1S1598F MEFs (Figure 3C). Assessment of
the signal distribution as described earlier in the text
revealed that disruption of BRCA1’s E3 ligase activity
did not impact on the distribution of 53BP1 at the foci,
whereas in contrast, a bimodal distribution failed to form
when the BRCT domain is impaired (Figure 3D). The
width of the IRIF size as assessed earlier in the text was
also diminished in the BRCT mutant cells (Figure 3D).
Thus, we conclude that BRCA1’s BRCT domain is
required for 53BP1 repositioning and generation of a
devoid core. These ﬁndings also support the role for
BRCA1 in repositioning 53BP1 and generating a devoid
core without relying on siRNA.
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POH1 is required for the generation of a devoid core of
53BP1 and ubiquitin chains via a process involving
RAP80/BRCC36/ABRAXAS
BRCA1’s BRCT domain mediates interaction with CtIP,
BACH1 and a complex encompassing RAP80-BRCC36-
Abraxas (16). As CtIP initiates HR upstream of BRCA1,
we considered it unlikely that CtIP is the factor mediating
BRCA1 function in 53BP1 repositioning. Normal 53BP1
foci enlargement and repositioning was observed follow-
ing siRNA RAP80, BRCC36 or BACH1 (Supplementary
Figure S4A). As the process involves repositioning of ubi-
quitin chains, we reasoned that it might require a DUB,
Figure 2. BRCA1 promotes 53BP1 repositioning in G2 creating a core devoid of 53BP1 and ubiquitin chains. (A and B) Analysis of G2 A549 cells at
0.5 (A) and 8 (B) h post 3Gy IR. Following immunostaining with the indicated antibodies, 3D IRIF analysis was undertaken. The red and green
signals represent 53BP1 and RPA, respectively; the blue signal is as indicated. Here, and in all cases where four antibodies were used, DAPI was
omitted. This allowed us to use a blue secondary antibody (Alexa 350) for identifying G2 phase cells. A typical example would be as follows: Rabbit
CENPF antibody coupled with a blue secondary antibody, rat RPA antibody coupled with a green secondary antibody, Rabbit BRCA1 antibody
(these foci are also visible in the blue channel but do not interfere with pan-nuclear appearance of CENPF) coupled with a red secondary antibody,
mouse 53BP1 coupled with a far red secondary antibody. ‘Wireframe’ images are displayed allowing 3D visualization. Foci volume enlarges from 0.5
to 8 h post-IR generating an expanded core lacking 53BP1. BRCA1 localizes internally to 53BP1 and RPA lies within the core. (C) Images following
siRNA BRCA1 8 h post-IR. Scale bars—5 and 0.5 mm in magniﬁed images. (D and E) Quantiﬁcation of ﬂuorescence intensity proﬁles along a line
drawn through the centre of IRIF at 8 h post-irradiation. In control cells (D) by 8 h post-IR, 53BP1 and FK2 IRIF are distributed in a bipolar
manner whilst in BRCA1k.d cells, single peaks persist. A minimum of 10 cells were analysed from each of three independent experiments. Error bars
represent SD. The 53BP1 and RPA foci intensity assessed in (E) represents an unbiased average of all IRIF after siRNA BRCA1 (i.e. those with or
without detectable RPA foci). Analysis of IRIF with RPA foci is shown in Supplementary Figure S3. The 53BP1 repositioning was impaired to the
same extent in IRIF with or without RPA foci after siRNA BRCA1. (F) Quantiﬁcation of IRIF clearance and overall size in Control and BRCA1
siRNA-treated cells. IRIF clearance represents the distance between the peaks in IRIF that show a bipolar distribution, whereas the foci size was
determined by measuring the distance between the outer edges of the peaks at 50% intensity. 53BP1 knockdown efﬁciency is shown in
Supplementary Figure S1. The size of the RPA peak was not estimated after siRNA BRCA1 due to the lack of a deﬁned peak.
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but surprisingly BRCC36 was not required
(Supplementary Figure S4A). A recent study showed
that the DUB, POH1, functions to restrict 53BP1
accumulation at IRIF by antagonizing RNF8/RNF168-
mediated ubiquitination and promoting JMJD2A chro-
matin retention, which competes with 53BP1 for binding
to dimethylated histone H4 residues (20). Hence, 53BP1
IRIF are enlarged at 1 h post 2 Gy IR following POH1
siRNA. We examined whether POH1 activity might have
a function in regulating 53BP1 localization during the pro-
gression of HR in G2 cells. First, we assessed the size of
53BP1 foci following POH1 siRNA in G1 cells at times up
to 8 h post-IR. The 53BP1 foci were enlarged at early
times following POH1 siRNA, although by 8 h, they
were of similar size to those in control cells
(Supplementary Figure S5A). In G2 cells, 53BP1 foci
were similar in size to those in control cells at 0.5 and
8 h post-IR (Figure 4A). These ﬁndings are consistent
with the previous conclusion that POH1 activity
antagonizes RNF8/RNF168-dependent ubiquitylation
and restricts 53BP1 foci size (20). However, the enlarge-
ment of 53BP1 in G1 cells following POH1 siRNA makes
it difﬁcult to evaluate whether POH1 downregulation or
restricted substrate access plays any role in the regulated
enlargement of 53BP1 foci in G2 cells. Strikingly,
however, although we observed 53BP1 foci expansion fol-
lowing POH1 siRNA, vacation of ubiquitin chains and
53BP1 from the core was greatly reduced, and RPA foci
did not form in the majority of cells (Figure 4A and B).
Consistent with this, RPA foci numbers were markedly
reduced following siRNA POH1 (Figure 4C).
Consolidating this, we observed that IR-induced RPA
Figure 3. The BRCT but not the RING domain of BRCA1 is required for resection, RAD51 loading and 53BP1 repositioning during HR in G2. (A)
Brca1FH-WT/FH-WT, Brca1FH-I26A/FH-I26A and Brca1S1598F/S1598F MEFs were irradiated with 3Gy IR in the presence of aphidocolin. Cells were har-
vested 8 h post-IR and immunostained with DAPI, RPA and p-H3 antibodies to identify G2 cells. (B) As for (A), but RAD51 foci were enumerated
2 h post 3Gy IR. (C) Analysis of 53BP1 foci volume in G2 phase Brca1FH-WT/FH-WT, Brca1FH-I26A and Brca1FH-S1598F MEFs 0.5 and 8 h following
3Gy IR. Analysis was carried out as in Figure 1C. (D) Quantiﬁcation of the intensity of 53BP1 in G2 phase Brca1FH-WT/FH-WT, Brca1FH-I26A and
Brca1FH-S1598F MEFs. Analysis was carried out as in Figure 2D. A minimum of 10 cells were analysed from three independent experiments. Error
bars represent SD.
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Figure 4. POH1 promotes resection in G2 by overcoming the inhibitory barriers of 53BP1 and RAP80. (A) 53BP1 foci volume was estimated in
A549 cells treated with the indicated siRNA as in Figure 1C. (B) A549 cells were immunostained with the indicated antibodies 8 h post 3 Gy. The far
left panels are a projection of the immunoﬂuorescence (IF) Z-stacked images. The 3D model conversions of these images are shown in the subsequent
panels. A devoid core of 53BP1 or FK2 does not form following siRNA POH1 but is visible following siRNA BRCC36+POH1. A single
oligonucleotide to POH1 was used, but similar results were obtained using a pool of siRNA POH1 oligonucleotides. RPA (C) and Rad51
(F) foci were enumerated in A549 cells treated with the indicated siRNA, and exposed to 3 Gy. (D) Resection was also assessed by monitoring
phosphorylation of RPA on Ser 4 and 8 by western blotting. A549 cells were irradiated with 30 Gy following siRNA transfection, and whole-cell
extracts were prepared at 2 h post-IR. (E) Depletion of BRCC36 or Abraxas results in loss of RAP80 demonstrating that they are required for
RAP80 stability. Knockdown efﬁciency following siRNA POH1 is shown in Supplementary Figure S1. The 53BP1 foci size was assessed in all G2
cells following siRNA POH1, regardless of whether they have RPA foci or not. Scale bars—5 mm and 0.5 mm in magniﬁed images.
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phosphorylation is POH1-dependent (Figure 4D).
Quantiﬁcation of the distribution of IRIF factors as
described earlier in the text conﬁrmed these ﬁndings
(Figure 5). The distinction between siRNA BRCA1,
which prevents expansion of 53BP1/ubiquitin chains and
the formation of a devoid core versus siRNA POH1,
which allows IRIF expansion but prevents devoid core
formation, is further substantiated by this analysis.
These ﬁndings strongly suggest that POH1 is required
for the generation of a core in the IRIF devoid of
53BP1 and ubiquitin chains, which appears to be a pre-
requisite for a normal level of RPA foci formation.
Recent studies have proposed that RAP80 suppresses
resection, as unbridled resection occurs following RAP80
siRNA (18). As depletion of RAP80, BRCC36 or
ABRAXAS enhances resection, we examined the impact
of combined POH1 and either siRNA RAP80, BRCC36
or ABRAXAS (17,18). In all cases, we observed normal
53BP1 enlargement but surprisingly a core devoid of ubi-
quitin chains and 53BP1 now formed (Figures 4A and B
and 5). Moreover, RPA foci formed in the core with foci
numbers returning to normal levels, although the foci were
smaller than in control cells (Figure 4B and C). These
ﬁndings were substantiated by the quantitative assessment
of foci parameters as discussed earlier in the text (Figure 5
and Supplementary Figure S6). As RAP80 binds to ubi-
quitin chains, we considered it likely that the ability of
siRNA BRCC36 or ABRAXAS to relieve the requirement
for POH1 was caused by the ability of BRCC36 and
ABRAXAS to interact with and stabilize RAP80 (18).
Consistent with this possibility, we observed diminished
expression of RAP80 following siRNA BRCC36 or
siABRAXAS (Figure 4E).
siRNA POH1 also resulted in markedly reduced
RAD51 foci numbers consistent with the dramatic reduc-
tion in RPA foci (Figure 4F). Unexpectedly, however,
siRNA POH1+BRCC36 did not restore RAD51 foci
formation despite promoting recovery of RPA foci
(Figure 4F). Thus, we conclude that POH1 has an add-
itional function in RAD51 loading, which is likely distinct
to its role in creating a 53BP1-devoid core to IRIF. This
ﬁnding is consistent with a role for POH1 in RAD51
loading as reported previously (20).
POH1 removes ubiquitin chains to promote loss of
RAP80 and 53BP1 from the core
Our quantitative analysis of protein/factor distribution at
the IRIF provided a means to assess changes to IRIF
arising following a range of combined knockdown condi-
tions. The ability of RAP80 to relieve the requirement for
POH1 to create a vacant core suggests that RAP80 might
be an additional factor that needs to be redistributed at
the IRIF to promote resection. We, therefore, additionally
examined the distribution of RAP80 at IRIF
(Supplementary Figure S5B). Like 53BP1, in control
cells, RAP80 vacates the core and is repositioned to the
periphery of enlarged IRIF (Supplementary Figure S5B
and Figure 5). This redistribution also requires BRCA1.
To gain insight into the order of events, we carried out
combined siRNA-mediated knockdown.
In previous work, we have shown that 53BP1 has a role
in heterochromatin relaxation by serving to tether ATM
at DSBs (28). This function is also required in G2 phase
cells and confers a role for 53BP1 in promoting HR at
HC-DSBs (manuscript submitted). To relieve this role of
53BP1 and focus on its inhibitory role in resection, we
carry out siRNA KAP-1, which serves to relax the HC
and overcomes the need for 53BP1 and ATM in DSB
repair. siRNA KAP-1 does not impact on the rate of
DSB repair in G2 phase cells or the IRIF enlargement
and core generation (data not shown). Consistent with
previous ﬁndings that loss of 53BP1 relieves the require-
ment for BRCA1 for HR, we observed that combined
siRNA KAP-1, 53BP1 and BRCA1 restored the bipolar
distribution of RAP80 and ubiquitin chains and allowed
RPA foci to form in the core (although less efﬁciently than
in control cells). The failure of these changes at IRIF to
arise following siRNA 53BP1+BRCA1 without siRNA
KAP1 is consistent with our ﬁnding that HR does not
proceed under these conditions (manuscript submitted).
The fact that RAP80 redistribution is also regained
raises the possibility that 53BP1 prevents access of
POH1 to ubiquitin chains and/or RAP80 and that
BRCA1 overcomes this block. Further, this analysis also
revealed that although the distribution of 53BP1 and
RAP80 was enlarged following siRNA POH1, neither
53BP1 nor RAP80 vacated the core region. Thus, both
POH1 and BRCA1 are required to generate a core
devoid of 53BP1, RAP80 and ubiquitin chains.
We next examined a range of additional situations; ﬁrst,
we co-depleted BRCA1, RAP80 and POH1 as well
as BRCA1+RAP80 but not POH1 (Figure 5 and
Supplementary Figure S6). In both cases, 53BP1, as
expected, remains within the IRIF core; additionally ubi-
quitin chains remain in the core. Thus, loss of RAP80
alone is insufﬁcient to promote loss of the FK2 chains
and BRCA1 function (to remove 53BP1) is additionally
required. Next, we depleted 53BP1 (and KAP-1) and
POH1. In this situation, we anticipated that RAP80
remains within the IRIF core and might prevent the loss
of ubiquitin chains; indeed, ubiquitin chains retained a
mono-polar distribution. Further consolidating this
notion, combined depletion of 53BP1, BRCA1, KAP-1
and POH1 caused a monopolar distribution of ubiquitin
chains. Interestingly, however, siRNA BRCA1 impacted
on the width of the IRIF and reduced the enlargement
otherwise observed following siRNA POH1 (see
‘Discussion’ section). Finally, we also examined
combined 53BP1 (and KAP-1) and RAP80 depletion. In
this case, both barriers limiting resection are removed, and
we anticipated that normal foci enlargement and clearance
would occur. As expected, the redistribution of ubiquitin
chains occurred and RPA foci formed in a devoid core
(Figure 5). As additional controls, we show that depletion
of RAP80 alone or 53BP1 combined with KAP1 does not
affect the redistribution of 53BP1 or ubiquitin chains.
Further, the repositioning of IRIF components is not
observed following siRNA CtIP, consistent with the
notion that under this condition DSB repair occurs by
NHEJ since resection is not initiated. In the situations
shown in Figure 5, depletion of BRCA1 or POH1
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Figure 5. Analysis of IRIF clearance from resection sites in G2 phase following combined siRNA treatments. Clearance of 53BP1, RAP80
and Ubiquitin chains from the IRIF core is required for resection to proceed normally. Here, the distribution of these factors is demonstrated
by quantiﬁcation of the ﬂuorescence intensity proﬁles along a line drawn through the centre of IRIF at 8 h post-irradiation (as in F). RPA foci
intensity was not assessed in those situations where foci numbers were substantially (<50%) decreased due inaccuracy in assessing the aver-
age intensity of two distinct populations. The requirement of various factors for the clearance of 53BP1, RAP80 and Ubiquitin chains was
analysed using combined siRNA-mediated knockdown. Knockdown efﬁciency following multiple siRNA transfection is shown in Supplementary
Figure S1. A minimum of 10 cells were analysed from three independent experiments. Error bars represent SD. Quantiﬁcation of IRIF clearance
and overall size in cells treated with the various combinations of siRNA-mediated knockdown is shown in Supplementary Figure S6. The data
for control cells and siRNA BRCA1 for 53BP1, ubiquitin chains and RPA foci is the same as that shown in Figure 2D and E. RAP80 analysis
is additional.
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resulted in a modest or very marked reduction in RPA foci
formation, respectively, except when BRCA1 was co-
depleted with 53BP1 or POH1 co-depleted with RAP80.
In all situations where 53BP1 foci and ubiquitin chains are
not repositioned, RPA foci formation is impaired (data
not shown).
In conclusion, the creation of an IRIF devoid core and
RPA foci formation requires both a BRCA1-dependent
impact on 53BP1 plus a POH1-dependent impact upon
RAP80. Failure to clear either 53BP1 or RAP80
prevents the clearance of ubiquitin chains and the ability
to form RPA foci normally.
DISCUSSION
Our ﬁndings reveal two distinct changes that take place at
IRIF in G2 phase during the progression of HR; the en-
largement of IRIF containing 53BP1, RAP80 and ubiqui-
tin chains and the formation of a core devoid of these
components. At early times in G2 phase, IRIF form in a
similar manner to those in G1 phase, with 53BP1 appear-
ing as tight foci overlapping with gH2AX. Subsequently
and speciﬁcally in G2, BRCA1 promotes relocalization of
all three components, 53BP1, RAP80 and ubiquitin chains
to the periphery of enlarged IRIF. gH2AX is not,
however, repositioned, although a core of reduced
gH2AX intensity does form, although less marked than
that observed for 53BP1. In parallel, RPA foci form in the
devoid core. The IRIF volume enlargement represents a
doubling in size. Although this could represent movement
along the DNA molecule, the volume increase occurs in
3D (i.e. spherically) rather than longitudinally raising the
possibility that it represents 53BP1 repositioning to en-
compass the undamaged sister homologue (see
Supplementary Figure S7 for details of a model). This
analysis of enlargement of 53BP1 foci is consistent with
but extends a previous study showing that BRCA1 repos-
itions 53BP1 to the foci periphery in S/G2 phase (15).
To facilitate analysis of these changes, we quantiﬁed the
protein distribution at IRIF using 3D reconstruction and
imaging analysis. As one approach, we monitored foci
volume, which revealed the 2-fold increase described
earlier in the text. Additionally, we monitored the distri-
bution of DNA damage response proteins along an axis
traversing the IRIF. Although there are limitations to this
latter analysis, the quantiﬁcation is fully consistent with
our visual observations and the quantiﬁcation of IRIF
volume. Although this approach revealed the presence of
a core with reduced occupancy of 53BP1 or ubiquitin
modiﬁcations, the magnitude of reduction is potentially
underrepresented. Indeed, the presence of a devoid core
is more evident visually. Nonetheless, the marked distinc-
tion using the quantiﬁcation approach allows an examin-
ation of factors regulating the process.
A previous study has reported that siRNA POH1
results in enlarged 53BP1 foci at 2 h post-IR in G1
phase cells and proposed that POH1 has a role in
antagonizing RNF8-RNF168-mediated ubiquitylation.
Our ﬁndings are consistent with this. Although the IRIF
enlargement speciﬁc to G2 phase cells at 8 h post-IR
occurred normally in POH1-depleted cells, it is unclear
whether speciﬁc downregulation of POH1 activity or
access underlies the regulated, G2-speciﬁc IRIF enlarge-
ment or whether it is an indirect consequence of POH1
siRNA as observed in G1 phase cells. Here, we focus on a
distinct and novel role for POH1 in generating a devoid
core region in IRIF. Our ﬁndings reveal the following
features: (i) BRCA1 has a previously undescribed
function in promoting clearance of RAP80 and ubiquitin
chains during HR. This role, however, involves a previ-
ously described impact on 53BP1 (12–14). Indeed, BRCA1
is dispensable for clearance of RAP80 and ubiquitin
chains in the IRIF core if 53BP1 is additionally
depleted. (ii) POH1 promotes RAP80 clearance from the
IRIF core but is not essential for the clearance of the
ubiquitin chains, as a bipolar distribution of ubiquitin
chains is regained following combined depletion of
POH1 and RAP80. RAP80 binds to K63 linked ubiquitin
chains via its tandem ubiquitin binding motif (17,18). It
has been proposed that RAP80 protects the ubiquitin
chains and that its loss leads to unbridled resection
(17,18). Thus, we propose that POH1 facilitates the
removal of RAP80, enabling degradation of the ubiquitin
chains possibly via other DUBs. However, we cannot
eliminate the possibility that POH1’s DUB activity
degrades the ubiquitin chains, which promote RAP80
loss and that in the absence of RAP80, they become ac-
cessible to other DUBs that are not normally exploited in
its controlled regulation.
53BP1 is known to be tethered at DSBs via its binding
to H4K20Me2 groups (29). Signiﬁcantly, the access of
these residues appears to be regulated by RNF8/
RNF168 dependent ubiquitylation of histone H2A and
potentially by competition with binding of JMJD2 (7,8).
A current model is that JMJD2 competes with 53BP1 for
H4K20me2 binding and is prevented by ubiquitin chains.
Thus, the loss of ubiquitin chains is likely a prerequisite
for 53BP1 clearance; indeed, POH1 has been reported to
regulate 53BP1 binding via its regulation of ubiquitin
chains (20). However, it has also been proposed that
valosin containing particle (VCP) regulates the unmasking
of 53BP1 chromatin binding sites (7). Our ﬁnding here
suggests that POH1 regulates 53BP1 binding and repos-
itioning during HR via a process involving the removal of
RAP80. Indeed, our ﬁndings show an unbroken relation-
ship between the loss of ubiquitin chains and resection in
the IRIF core; that is, the ubiquitin chains must be lost to
allow normal resection. This process necessitates loss of
53BP1 and RAP80 from the core consistent with their
previously described functions in restricting resection.
It is perhaps, noteworthy, that although POH1 deple-
tion allows the IRIF to expand to a similar extent to that
observed in control cells at 8 h in G2 cells, this impact is
reduced when combined with BRCA1 siRNA. This effect
cannot be attributed entirely to BRCA1’s impact on
53BP1, as it is also observed following co-depletion of
BRCA1 and 53BP1. BRCA1 clearly has a role in
promoting IRIF enlargement in G2 phase cells, which is
likely distinct to its role in generating a devoid core. Our
ﬁndings do not address whether downregulation of POH1
contributes to this process, and we surmise that the IRIF
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enlargement observed at 8 h in G2 cells following POH1
maybe a consequence of its previously described role in
counterbalancing RNF8/RNF168-dependent ubiquityla-
tion. It is possible, however, that BRCA1 speciﬁcally
facilitates new RNF8/RNF168 ubiquitylation events
during this G2-speciﬁc event.
Interestingly, our ﬁndings here reveal that 53BP1
enlarges in G2 phase without the concomitant
enlargement of gH2AX. Previous studies have suggested
that RNF168 can, via its RING domain and several ubi-
quitin-binding domains, amplify ubiquitin conjugates
generated by its own activity and hence extend the
region of histone ubiquitylation (30–33). This process
appears to be restricted by several DUBs as well as by
the ubiquitin ligases, TRIP12 and UBR5 (33). As a step
towards revealing how 53BP1 might relocalize without
gH2AX, we examined whether RNF168 also becomes
relocalized. As the available RNF168 antibodies were
not efﬁcient for immunoﬂuorescence, we expressed GFP-
tagged RNF168. Signiﬁcantly, in cells where 53BP1 foci
were of similar size to those in control cells, we observed
RNF168 relocalization to the foci periphery in a similar
manner to 53BP1 (Supplementary Figure S4C). This
suggests that RNF168’s ability to extend the region of
ubiquitylation may underlie 53BP1 expansion. However,
further studies are required to understand the detailed
regulation of this step.
Our ﬁndings demonstrate that 53BP1 and RAP80 rep-
resent two barriers to resection and that BRCA1 and
POH1, respectively, function in an interfacing manner to
overcome these barriers. Our data show that these are not
simply alternative barriers, as one barrier is not relieved
without the other and vice versa. We propose the follow-
ing linear model for clearance of RAP80 and 53BP1 from
the IRIF core (Figure 6). The process is initiated by a
BRCA1-dependent ‘priming’ of 53BP1. As this requires
BRCA1’s BRCT domain, we suggest that it could
involve BRCA1’s modulation of 53BP1 position via
binding to phosphorylated 53BP1. This process removes
an inhibitory impact of 53BP1 on POH1, allowing it to
access RAP80 and/or ubiquitin chains. POH1, as a com-
ponent of the proteasome, may directly degrade RAP80,
which allows access of ubiquitin chains to another DUB,
or POH1 could remove the ubiquitin chains, which
triggers loss of RAP80. As discussed earlier in the text,
we favour the ﬁrst possibility. Loss of the ubiquitin chains
promotes binding of JMJD2, which promotes loss of
53BP1 by competitive binding to H4K20Me3 residues.
Thus, BRCA1 initiates a cascade of events, which
together with POH1 allow the formation of a core
region in IRIF devoid of RAP80 and 53BP1, where
RPA foci form. In summary, an emerging model for
DSB repair in G2 phase cells is that NHEJ makes an
initial attempt to repair DSBs, but resection and hence
HR occurs when repair by NHEJ does not progress.
The regulation of resection is a complex process that is
critical to determine the choice between HR and NHEJ.
At least two complexes, RAP80 and 53BP, function to
prevent immediate DSB resection and allow NHEJ
to attempt repair. We show here that resection re-
quires the generation of a core region in IRIF devoid of
53BP1, RAP80 and ubiquitin chains and that RPA foci
form in this devoid core. Both BRCA1 and POH1 are
required for this process. We demonstrate a direct role
for POH1 in clearing RAP80 in the IRIF core and an
indirect role for BRCA1, which necessitates its impact
on 53BP1.
Figure 6. Model showing the removal of the inhibitory barriers posed to
resection by 53BP1, RAP80 and Ubiquitin chains. Following the induc-
tion of DSBs, several factors including 53BP1, BRCA1 and RAP80
rapidly accumulate and form IRIF. The recruitment of 53BP1 and
BRCA1 is dependent on the formation of ubiquitin chains at DSBs,
which also form IRIF and can be visualized by antibodies that detect
conjugated ubiquitin (a-FK2). Three complexes (BRCA1A-C) involving
BRCA1 have been described (16). BRCA1-A comprises ABRAXAS,
RAP80, BRCC36, BRCC45 and MERIT40. The presence of 53BP1,
RAP80 and ubiquitin chains promote repair via NHEJ, as they are in-
hibitory to HR by blocking the process of resection. In G2 phase, the
inhibitory barrier posed by these factors needs to be overcome for resec-
tion to proceed. Initially, BRCA1, via a process that requires its BRCT
domain, ‘primes’ 53BP1 to allow POH1 access to RAP80. In the absence
of BRCA1, both 53BP1 and RAP80 remain in the IRIF core. POH1
promotes the clearance of RAP80, which in turn allows removal of the
ubiquitin chains from the IRIF core possibly via a DUB activity. This, in
turn, promotes the full clearance of 53BP1 from the IRIF core. Thus,
BRCA1 alone is not sufﬁcient to promote clearance of 53BP1 from the
core; POH1 is additionally required. Likewise, BRCA1 and POH1 are
required to promote the clearance of RAP80 from the core. Once all
these factors have been cleared from the IRIF core, nucleases can
promote 50-30 resection, thus allowing repair by HR to proceed. We
have proposed a linear feedback model to accommodate the ﬁnding
that depletion of BRCA1 or POH1 can block clearance of both
RAP80 and 53BP1, demonstrating that they are inter-dependent
barriers. In the model shown, we have only depicted the removal of
proteins/modiﬁcations from the IRIF core and have not included the
repositioning of the proteins to the periphery of the foci.
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